EDGEWELL PERSONAL CARE Co Q4 FY2026 earnings call

• Strategic Shift to Brand Equity: Management has shifted commercial investment away from short-term couponing toward sustained brand building, increasing Advertising & Promotional (A&P) spending by 7% in FY26 and planning further increases in FY27. This strategy aims to build long-term consumer loyalty rather than transactional volume.
• Portfolio Simplification: The divestiture of the feminine care business has simplified the portfolio, allowing focused resources on priority brands (Schick, Billy, Cremo, Hawaiian Tropic) under the unifying theme of skin nurturing and protection.
• Operational Transformation: The company is accelerating a broader operating model transformation beyond manufacturing, including simplifying structures, strengthening procurement, and leveraging AI/advanced analytics to create a structurally lower cost base and improve agility.
• Manufacturing Consolidation Challenges: The consolidation of the North American wet shave manufacturing footprint into a new greenfield site is proceeding but is more challenging than anticipated. The timeline has shifted by six months, pushing associated savings to begin in FY28 rather than FY27.
• Retailer Partnership Improvements: Enhanced brand support and innovation have led to improved relationships with key retailers like Walmart and Target, resulting in better shelf placement, increased distribution, and positive trade outcomes.
• Innovation Pipeline: A robust pipeline of innovation is underway, including new product launches for Cremo (expanding into body wash and antiperspirant), Schick First Acne Safe in Asia, and significant upgrades to the Billy brand in the US.

The company operates in three primary continuing segments: Grooming, Wet Shave, and Sun & Skincare. For the full year 2026, Grooming drove the top-line growth with nearly 13% organic sales increase, fueled by strong performance from brands like Cremo and Bulldog. Wet Shave experienced a slight decline of approximately 1%, as roughly 2% growth in branded wet shave was offset by a significant ~10% drop in private label sales due to supply chain consolidation disruptions. Sun & Skincare saw modest overall growth, though this masked divergent trends: the sub-segment grew 3% driven by grooming, while pure Sun Care declined slightly due to unfavorable weather conditions in Europe and Latin America. In terms of revenue contribution, North America and International each represent roughly half of total sales, with both regions returning to organic growth in Q4.

• Organic Net Sales: Expected to grow between 1% and 3% for Fiscal 27, with growth expected in both North America and International markets.
• Adjusted Gross Margin: Expected to expand by approximately 60 basis points year-over-year, driven by productivity, procurement savings, and revenue management initiatives, partially offset by energy-related inflation.
• Adjusted Operating Profit: Expected to grow by approximately 10%, supported by gross margin expansion, lower SG&A, and organic sales growth, despite higher A&P investments.
• Adjusted EPS: Projected range of $1.85 to $2.15 per share (midpoint ~$2.00), absorbing headwinds from the expiration of TSA income and a higher effective tax rate (~24%).
• Adjusted EBITDA: Expected range of $250 million to $270 million (midpoint ~$260 million), representing approximately 2% growth at the midpoint.
• Adjusted Free Cash Flow: Expected range of $100 million to $120 million, inclusive of restructuring charges.
• Phasing: Significant phasing imbalance is expected, with two-thirds of adjusted EBITDA and ~80% of adjusted EPS generated in the second half of the year due to front-loaded A&P spend and back-loaded cost savings.

• Manufacturing Transition Risks: The consolidation of wet shave manufacturing facilities is causing supply constraints, particularly impacting private label sales and creating operational complexity that delayed savings realization.
• Macroeconomic Headwinds: Elevated inflation, specifically in energy costs (oil/diesel freight), tariffs, and commodity prices, poses significant pressure on gross margins.
• Tax Rate Increase: The expiration of transition service agreement (TSA) income from the FemCare divestiture and a higher effective tax rate (~24%) will negatively impact net earnings.
• Private Label Volatility: Continued disruption in private label wet shave sales due to supply chain issues remains a drag on segment performance until production capacity stabilizes in the latter half of FY27.
• Currency Fluctuations: Foreign currency translation is expected to be a headwind, impacting reported net sales and earnings.

Q: Nick Amodi asked about the consumer backdrop assumptions in guidance and how retail shelf space dynamics are evolving as the company regains momentum. / A: Rod Little stated guidance assumes category volumes perform consistent with the last 6-12 months, noting steady price-based demand despite consumer sensitivity. He emphasized that increased marketing investment (rising from 10% to 13% of sales) is driving positive retailer responses, resulting in better shelf positioning, more distribution, and stronger in-store displays globally, which validates their strategy of trading up to brand equity over promotional discounting.

Q: Peter Grom sought clarity on the long-term margin opportunity and specific inflation components embedded in the FY27 outlook. / A: Rod Little explained that long-term margin expansion relies on three levers: optimizing gross/net mix, pricing power derived from improved brand health/share, and SG&A leverage/cost reductions. Fran Weissman detailed that FY27 inflation is estimated at ~300 basis points, driven by core inflation, tariff annualization, and oil prices (EIA mid-$80s outlook). She noted this is largely mitigated by >250 basis points of productivity gains, volume absorption, and revenue management initiatives.

Q: Chris Carey inquired about the evolution of private label headwinds through FY26 and visibility on supply constraint improvements across geographies. / A: Rod Little clarified that private label declines (~10%) were driven entirely by supply constraints from the wet shave plant consolidation, not consumer demand. He noted the project is ~50% complete, with constraints peaking in Q1 FY27 before moderating. Savings are deferred to FY28-29. Internationally, production output is recovering, evidenced by European growth in Q4, while North America expects private label to return to growth in H2 FY27.

Q: Olivia Tong requested a comparison of Shave vs. Sun/Skin performance and expectations for rate of change in FY27, specifically regarding Banana Boat. / A: Fran Weissman highlighted that while Sun & Skincare had mixed results due to weather, branded wet shave and grooming are showing strong, stabilized growth. She noted Hawaiian Tropic gained 280 bps share, while Banana Boat declined but overall unit share rose 90 bps. Rod Little added that FY27 will be unique because all segments (Grooming, Sun, Shave) and geographies (NA, Int’l) are projected to grow simultaneously, eliminating previous 'leaky buckets' through improved execution and innovation pipelines.